Sterling Consolidated Corp. STCC
Last Post: 11/29/2018 11:18:53 AM
Board Marks: 4
Posts Today: 0
Board Views Today: 23
11/03/2016 4:24:04 PM
11/03/2016 4:23:38 PM
11/03/2016 2:48:48 PM
11/03/2016 2:47:48 PM
11/03/2016 2:47:12 PM
11/03/2016 1:21:59 PM
11/03/2016 1:21:10 PM
11/03/2016 1:20:38 PM
11/03/2016 12:38:32 PM
11/03/2016 12:37:39 PM
11/03/2016 12:36:56 PM
11/02/2016 4:22:10 PM
11/02/2016 4:21:47 PM
11/02/2016 4:21:23 PM
11/02/2016 2:53:17 PM
11/02/2016 2:52:24 PM
11/02/2016 2:51:55 PM
11/02/2016 12:34:26 PM
11/02/2016 12:33:34 PM
11/02/2016 12:32:28 PM
11/02/2016 11:58:00 AM
11/02/2016 11:57:06 AM
11/02/2016 11:56:34 AM
11/01/2016 2:09:38 PM
11/01/2016 2:09:07 PM
11/01/2016 2:08:40 PM
11/01/2016 1:50:48 PM
11/01/2016 1:50:00 PM
11/01/2016 1:49:25 PM
11/01/2016 12:00:53 PM
11/01/2016 11:59:46 AM
11/01/2016 11:58:53 AM
11/01/2016 11:16:42 AM
11/01/2016 11:16:01 AM
11/01/2016 11:15:06 AM
10/31/2016 2:54:10 PM
10/31/2016 2:53:33 PM
10/31/2016 2:53:04 PM
10/31/2016 2:52:40 PM
10/31/2016 2:52:04 PM
10/31/2016 2:51:27 PM
10/31/2016 1:48:27 PM
10/31/2016 1:47:34 PM
10/31/2016 1:46:24 PM
10/31/2016 12:20:52 PM
10/31/2016 12:19:38 PM
10/31/2016 12:18:18 PM
10/28/2016 12:52:29 PM
10/28/2016 12:51:56 PM
10/28/2016 12:51:32 PM
Recent Articles
- Samsung Chairman's Family Sells Shares to Meet Inheritance Tax
- Clinical Breakthrough: ITM's Promising Trial Results Unveiled
- Celcuity's Promising Phase 1 Trial Results on Prostate Cancer Therapy
- New Findings on Gedatolisib’s Efficacy for Advanced Breast Cancer
- Concerns Raised Over Elon Musk's Striking Compensation Package
- Qustodio: Elevating Digital Child Safety on iPhones in 2025
- Celcuity's Phase 3 VIKTORIA-1 Trial for PIK3CA Mutants Advances
- Innovative Gedatolisib and Darolutamide Study Shows Promise
- New Insights on Gedatolisib's Role in Breast Cancer Treatment
- Meta and Blue Owl Collaborate on $30 Billion AI Data Center
- Kura Oncology's Latest Insights on FTI Program Advancements
- Nvidia's Market Share Plummets: CEO Jensen Huang's Concerns
- Kura Oncology Unveils Promising Data from FTI Programs at ESMO
- Olema Oncology Shares Promising Findings on Palazestrant
- General Oncology's SHARON Trial Yields Encouraging Results
- Revitalizing ER+ Breast Cancer with Palazestrant and Ribociclib
- Corbus Pharmaceuticals Reports Promising Results for CRB-701
- Promising Data on NX-1607: A Breakthrough in Cancer Treatment
- Florida Cancer Specialists Revolutionizing Oncology Research
- Salesforce CEO's Apology Sparks Controversy in Tech Industry
- Significant Progress in Advanced Breast Cancer Treatments with Giredestrant
- Breakthrough in HPV Carcinoma Treatment by SCG Cell Therapy
- Innovative Immunotherapy SCG142 Shows Promise in Cancer Treatment
- Trump's Decision on Ukraine Missiles Revealed After Key Talks
- Kevin O'Leary Highlights Importance of American Dream for Leadership
- Transformational Program for Millennial Professionals Unveiled
- Investigation Launched as PeopleGuru Faces Data Breach Crisis
- Trump Seeks Supreme Court Approval for National Guard in Chicago
- Westhaven Gold Corp. Announces Executive Update and Future Plans
- Trump Commutes Santos' Prison Sentence Amid Public Support
- A New Toolkit to Enhance Executive Function Skills in Education
- Westhaven Gold Announces Leadership Changes and Operations Update
- Aeroméxico's Exciting Global Offering: What You Need to Know
- Investigation Into Luminar Technologies Signals Serious Concerns
- Inquiry into Hasbro Leadership: Legal Investigation Unfolds
- Legal Investigation of CVS/Aetna Medicare Advantage Claims
- Deadline Approaches for Dow Investors in Class Action Case
- Investors Alert: Key Class Action Lawsuit Against V.F. Corporation
- Fluor Corporation Lawsuit Update: Important Investor Info
- Investors Urged to Act Before KBR Class Action Deadline
- Cytokinetics Class Action Lawsuit Update: Important Deadlines
- Important Legal Update for WPP Investors: Key Deadline Approaches
- Molina Healthcare Faces Class Action Lawsuit Amid Financial Turmoil
- Marex Group Faces Class Action Lawsuit Over Financial Misconduct
- Lead the Charge: Join the Fly-E Group Securities Lawsuit
- Investigation into MoonLake Immunotherapeutics Raises Concerns
- MoonLake Immunotherapeutics: Investors Investigate Potential Fraud
- Investigation of MoonLake Immunotherapeutics Raises Concerns
- Leadership Changes at Silver Mountain Resources: What to Expect
- Canton Fair Launches Enhanced Services to Boost Global Trade
